Neorelief Wound Care Cream
NDC Package 58368-006-06
Package Information
Neorelief Wound Care (homeopathic healing cream) cream is wash hands before and after use; spread a thin layer of Wound Care on the clean affected area; Apply as needed 2-3 times daily. This formulation utilizes a cream delivery system. Marketed by Biolyte Laboratories, Llc, this product is identified by NDC 58368-006.
Identification & Billing
Clinical Specifications
- ALTHAEA OFFICINALIS ROOT 3 [hp_X]/g
- CALENDULA OFFICINALIS FLOWERING TOP 3 [hp_X]/g
- DAPHNE MEZEREUM BARK 3 [hp_X]/g
- EQUISETUM ARVENSE TOP 3 [hp_X]/g
- HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK 3 [hp_X]/g
- HORSE CHESTNUT 3 [hp_X]/g
- SALIX ALBA BARK 3 [hp_X]/g
- STELLARIA MEDIA 3 [hp_X]/g
- URTICA URENS 2 [hp_X]/g
Regulatory & Marketing
Hierarchy Structure
- 58368 - Biolyte Laboratories, Llc
- 58368-006 - Neorelief Wound Care
- 58368-006-06 - 14.17 g in 1 BOTTLE, PUMP
- 58368-006 - Neorelief Wound Care
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58368-006-06 identifies a specific commercial package of 14.17 g in 1 bottle, pump of Neorelief Wound Care, a human over the counter drug labeled by Biolyte Laboratories, Llc. This cream is formulated for topical use and contains althaea officinalis root; calendula officinalis flowering top; daphne mezereum bark; equisetum arvense top; hamamelis virginiana root bark/stem bark; horse chestnut; salix alba bark; stellaria media; urtica urens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biolyte Laboratories, Llc on April 27, 2018. The current certification is valid through December 31, 2027.
How is this Biolyte Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58368000606. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.